ReviewStem cells (Dayton, Ohio)2026

Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation.

Qifeng Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.